中國船舶(600150.SH):公司吸收合併中國重工事項獲得上交所併購重組審核委員會審核通過
格隆匯7月4日丨中國船舶(600150.SH)公佈,中國船舶工業股份有限公司(簡稱“中國船舶”、“公司”)擬向中國船舶重工股份有限公司(簡稱“中國重工”)全體換股股東發行A股股票的方式換股吸收合併中國重工。上海證券交易所併購重組審核委員會於2025年7月4日召開2025年第8次併購重組審核委員會審議會議,對公司本次交易的申請進行了審議。根據上交所併購重組審核委員會發布的《上海證券交易所併購重組審核委員會2025年第8次審議會議結果公吿》,本次會議的審議結果為:本次交易符合重組條件和信息披露要求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.